-+ 0.00%
-+ 0.00%
-+ 0.00%

Argus Research Maintains Buy on Versigent, Raises Price Target to $54

Benzinga·08/13/2026 13:12:56
語音播報
Argus Research analyst Bill Selesky maintains Versigent (NYSE:VGNT) with a Buy and raises the price target from $50 to $54.